Weight-Loss Drugs Fueling Surge in Belt Adjustments, Retail Executive Claims
A significant increase in customers needing extra holes punched in their belts suggests widespread adoption of weight-loss medications, according to the chief executive of Timpson.
The growing popularity of weight-loss injections like Ozempic and Mounjaro is leading to a surge in customers needing their belts tightened, according to Lord James Timpson, chief executive of the retail chain Timpson.
Timpson shops have reported a 680% increase in the number of customers requiring additional holes to be punched in their belts over the past year. Timpson suggested that this trend is directly linked to the increased uptake of weight-loss medications.
"We can only assume that this is due to the recent uptake in weight-loss injections," Timpson stated on X, formerly Twitter. He also noted that the increase in customers losing weight has positively impacted donations to the company's charity, the Alex Timpson Trust, which supports looked-after children.
Estimates suggest approximately 2.4 million people in the UK are currently prescribed weight-loss medications. The majority of these individuals reportedly pay privately for drugs such as Mounjaro or semaglutide (known as Wegovy for weight loss and Ozempic for diabetes), as access through the National Health Service (NHS) is restricted. In June, the medicines regulator approved Wegovy in a tablet form.
Olivier Picard, chairman of the National Pharmacy Association, commented on the trend, stating, "It is encouraging to see more and more people needing extra notches in their belts after starting weight management treatments." He highlighted obesity as a major societal health challenge and emphasized the transformative effect weight-loss treatments can have on eligible individuals' health outcomes.
Picard urged for increased efforts from the government and the NHS to leverage pharmacies in providing these treatments to more eligible patients. He expressed concern about the slow rollout of weight management services via GPs and the existing "postcode lottery" for access, asserting that community pharmacies are prepared to support a wider distribution to help mitigate the impact of obesity on the NHS.